1. Home
  2. ENVB vs LICN Comparison

ENVB vs LICN Comparison

Compare ENVB & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVB
  • LICN
  • Stock Information
  • Founded
  • ENVB 1994
  • LICN 2004
  • Country
  • ENVB United States
  • LICN China
  • Employees
  • ENVB N/A
  • LICN N/A
  • Industry
  • ENVB Biotechnology: Pharmaceutical Preparations
  • LICN
  • Sector
  • ENVB Health Care
  • LICN
  • Exchange
  • ENVB Nasdaq
  • LICN Nasdaq
  • Market Cap
  • ENVB 3.1M
  • LICN 3.1M
  • IPO Year
  • ENVB N/A
  • LICN 2023
  • Fundamental
  • Price
  • ENVB $1.32
  • LICN $4.44
  • Analyst Decision
  • ENVB Strong Buy
  • LICN
  • Analyst Count
  • ENVB 1
  • LICN 0
  • Target Price
  • ENVB $10.00
  • LICN N/A
  • AVG Volume (30 Days)
  • ENVB 107.1K
  • LICN 22.6K
  • Earning Date
  • ENVB 08-11-2025
  • LICN 01-01-0001
  • Dividend Yield
  • ENVB N/A
  • LICN N/A
  • EPS Growth
  • ENVB N/A
  • LICN N/A
  • EPS
  • ENVB N/A
  • LICN N/A
  • Revenue
  • ENVB N/A
  • LICN $41,477,000.00
  • Revenue This Year
  • ENVB N/A
  • LICN N/A
  • Revenue Next Year
  • ENVB N/A
  • LICN N/A
  • P/E Ratio
  • ENVB N/A
  • LICN N/A
  • Revenue Growth
  • ENVB N/A
  • LICN 4.32
  • 52 Week Low
  • ENVB $1.01
  • LICN $2.60
  • 52 Week High
  • ENVB $11.55
  • LICN $488.00
  • Technical
  • Relative Strength Index (RSI)
  • ENVB 57.52
  • LICN 53.94
  • Support Level
  • ENVB $1.19
  • LICN $4.02
  • Resistance Level
  • ENVB $1.28
  • LICN $4.41
  • Average True Range (ATR)
  • ENVB 0.06
  • LICN 0.25
  • MACD
  • ENVB 0.02
  • LICN 0.05
  • Stochastic Oscillator
  • ENVB 91.48
  • LICN 92.57

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

Share on Social Networks: